Japan stocks higher at close of trade; Nikkei 225 up 0.43%
Post Content
Post Content
Post Content Post Views: 83
Post Content Post Views: 80
Post Content Post Views: 86
Post Content Post Views: 83
Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024. Post Views: 81
Post Content Post Views: 84